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Abstract
Objective
Association between ankylosing spondylitis (AS) and two genes, ERAP1 and IL23R, has recently been reported in 
North American and British populations. The population attributable risk fraction for ERAP1 in this study was 25%, and 
for IL23R, 9%. Conﬁrmation of these ﬁndings to ERAP1 in other ethnic groups has not yet been demonstrated. We sought 
to test the association between single nucleotide polymorphisms (SNPs) in these genes and susceptibility to AS among a 
Portuguese population. We also investigated the role of these genes in clinical manifestations of AS, including age of 
symptom onset, the Bath Ankylosing Spondylitis Disease Activity, Metrology and Functional Indices, and the modiﬁed 
Stoke Ankylosing Spondylitis Spinal Score.
Methods
The study was conducted on 358 AS cases and 285 ethnically matched Portuguese healthy controls. AS was deﬁned 
according to the modiﬁed New York Criteria. Genotyping of IL23R and ERAP1 allelic variants was carried out with 
TaqMan allelic discrimination assays. Association analysis was performed using the Cochrane-Armitage and linear 
regression tests of genotypes as implemented in PLINK for dichotomous and quantitative variables respectively. 
A meta-analysis for Portuguese and previously published Spanish IL23R data was performed using the StatsDirect® 
Statistical tools, by ﬁxed and random effects models.
Results
A total of 14 nsSNPs markers (8 for IL23R, 5 for ERAP1, 1 for LN-PEP) were analysed. Three markers (2 for IL23R and 
1 for ERAP1) showed signiﬁcant single-locus disease associations, conﬁrming that the association of these genes with AS 
in the Portuguese population. The strongest associated SNP in IL23R was rs1004819 (OR=1.4, p=0.0049), and in ERAP1 
was rs30187 (OR=1.26, p=0.035). The population attributable risk fractions in the Portuguese population for these SNPs 
are 11% and 9.7% respectively.  No association was seen with any SNP in LN-PEP, which ﬂanks ERAP1 and was 
associated with AS in the British population. No association was seen with clinical manifestations of AS.
Conclusions
These results show that IL23R and ERAP1 genes are also associated with susceptibility to AS in the Portuguese 
population, and that they contribute a signiﬁcant proportion of the population risk for this disease.
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Introduction
Ankylosing spondylitis (AS) is a chron-
ic inﬂammatory disorder with an esti-
mated prevalence of 0.1–0.9% in Cau-
casian populations (1, 2). Although the 
contribution of the HLA-B27 allele to 
the overall genetic predisposition has 
been estimated at 20-30% and the con-
tribution of all genes in the HLA region 
estimated at 40-50% (3), genes outside 
the major histocompatibility complex 
are strongly implicated in the aetiology 
of the disease. In particular, the genes 
IL23R and ERAP1 have recently been 
demonstrated to be associated with AS 
in British and North American Cauca-
sians (4). The population attributable 
risk fraction for ERAP1 in this study 
was 25%, and for IL23R, 9% (4). As-
sociation of the IL23R ﬁndings has 
recently been conﬁrmed in Canadian 
(5) and Spanish populations (6), but 
not yet been demonstrated for ERAP1. 
We sought to test the association be-
tween single nucleotide polymorphisms 
(SNPs) in these genes and susceptibil-
ity to AS in the Portuguese population. 
We also investigated the role of these 
genes in the pattern of AS clinical mani-
festations, including age of symptom 
onset and the Bath Ankylosing Spond-
ylitis Disease Activity (BASDAI) (7), 
Functional (BASFI) (8) and Metrology 
(BASMI) (9) Indices, and the modiﬁed 
Stoke Ankylosing Spondylitis Spinal 
Score (10).
Methods 
Subject
The study group comprised 358 unre-
lated AS patients and 285 ethnically 
matched healthy controls. Individuals 
included in the study were of Portu-
guese ancestry and came from main-
land Portugal. All cases were diagnosed 
as having AS according to the modiﬁed 
New York Criteria (11). Cases were re-
cruited from hospital outpatient depart-
ments; controls were healthy Portu-
guese bone marrow donors. This study 
was approved by the Ethics Board of 
the involved centres, and written in-
formed consent was obtained from the 
individuals involved in this study.
Patients completed a questionnaire 
containing a self-assessment of clinical 
features, including the BASDAI and 
the BASFI. Metrology was performed 
by one of the investigators (FS), to ob-
tain the BASMI. Age at disease onset 
was deﬁned as the age at onset of clini-
cal symptoms. Similarly, disease dura-
tion was deﬁned as the period (years) 
after the onset of clinical symptoms.
 
Genotyping
Genomic DNA from cases and controls 
individuals was prepared from periph-
eral blood lymphocytes using standard 
techniques. Samples were genotyped 
for the 14 nsSNPs markers used in the  
Wellcome Trust Case-Control Consorti-
um/Australo-Anglo-American Spondy-
loarthritis Consortium (WTCCC/TASC) 
study (4). Eight SNPs were typed in and 
around IL23R (rs1495965, rs10489629, 
rs11465804, rs10889677, rs1343151, 
rs1004819, rs11209026, rs11209032), 
5 in ERAP1 (rs2287987, rs30187, 
rs10050860, rs27044, rs17482078) and 
1 in LN-PEP (rs2303138). Taqman® 
SNP genotyping assays (Applied Bio-
systems, Foster City, USA) were used 
for genotyping, which was performed 
according to the manufacturers proto-
cols (see Table I). 
Genotyping reactions were performed 
with an AB 7900HT, and the allele call 
by the analysis of allelic discrimination 
plots with AB SDS 2.3 software. Rep-
licate genotype known and negative 
control samples were typed in each 96 
well plate. 
Statistical analysis
SNP genotype data was assessed for 
missingness (overall, and differences , 
cases and controls assessed by χ2 test) 
and for Hardy-Weinberg equilibrium in 
controls. Individuals with >10% miss-
ingness were excluded (n=5 controls, 2 
cases).
Association analysis was performed 
using the Cochrane-Armitage test as 
implemented in PLINK (12). Associa-
tion between SNPs and the quantitative 
variables age of symptom onset, BAS-
DAI, BASFI, BASMI and mSASSS 
were tested by linear regression assum-
ing an additive model using PLINK, 
taking into account gender and disease 
duration as covariates.
Imputation analyses were carried out us-
ing Markov Chain Haplotyping software 
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(MaCH; http://www.sph.umich.edu/csg/
abecasis/MACH/) using phased data 
from CEU individuals from release 22 of 
the HapMap project as the reference set 
of haplotypes. We only analyzed SNPs 
that were either genotyped or could be 
imputed with relatively high conﬁdence 
(R2>=0.3).Association analysis of im-
puted SNPs was performed assuming 
an underlying additive model using the 
software package MACH2ASSOC (Li, 
Willer, Ding, Scheet and Abecasis, un-
published data) which accounts for un-
certainty in prediction of the imputed 
data by weighting genotypes by their 
posterior probabilities.
A meta-analysis study was performed 
using StatsDirect® software (13), spe-
ciﬁcally to test the association of IL23R 
in the Iberian population, combining 
the Portuguese data presented here, and 
previously published Spanish data (6). 
Both ﬁxed and random effects analy-
sis was performed; non-combinability 
of studies was assessed using the Co-
chrane Q statistic, and the extent of 
heterogeneity between studies assessed 
using the I2 statistic. Power calculations 
were performed using the Genetic Pow-
er Calculator (14).
Results
The Portuguese AS cohort population 
(Table II) included 228 (63.5%) men 
and 132 (36.5%) women with a mean 
age of 45.4 (±13.2 SD) years (range 20-
79 years) and a mean disease duration 
of 19.1 (±12.6) years (range 0-60 years), 
of whom 82% were HLA-B27 positive. 
Epidemiological data of the cases and 
controls are summarized in Table II.
All the studied genetic markers were in 
Hardy-Weinberg equilibrium in the con-
trols group, had missingess rates <10%, 
and none had differential missingness in 
cases and controls (p<10-2). The minor 
allele frequencies (MAF) of the 14 SNPs 
are presented in Tables III and IV. 
Single-marker association tests revealed 
signiﬁcant AS associations for the 
ERAP1 SNP rs30187 (odds ratio (OR) 
1.26, p=0.035) and rs27044 (OR 1.26, 
p=0.044) (Table III). Unlike in the previ-
ous British and North American studies, 
no association was seen with the SNP 
rs2303138, which lies within LN-PEP, 
which ﬂanks ERAP1. Of the 119 SNPs 
imputed in and around ERAP1, 32 dem-
onstrated nominal association with AS 
(p<0.05), with the strongest association 
being with rs41135 (p=0.014) (Fig. 1).
Two SNPs in and around IL23R dem-
onstrated signiﬁcant association 
(rs1004819 OR=1.44, p=4.9x10-3; 
rs10889677 OR=1.41, p=5.8x10-3) 
(Table IV). The strongest associated 
SNP reported in both Crohn’s disease 
(15) and psoriasis (16) (Arg381Gln; 
rs11209026) did not show any protec-
tive effect in our population. No imputed 
SNP was more strongly associated with 
AS than these two genotyped SNPs, 
but many SNPs in a block extending 
from rs10889667 as far as rs11465817 
(67493685 bp from the p-telomere) 
were associated with AS with p<0.01 
(Fig. 2). Of the 49 imputed SNPs in and 
around IL23R, 23 demonstrated nomi-
nal association with AS (p<0.05).
Table I. IL23R, ERAP1 and LN-PEP genetic variants analysed in AS patients and controls. 
Positions are given as per dbSNP build 129.
Genes Chromosome Position (bp)* Gene location Taqman ASSAY ID NCBI SNP 
     Reference
IL23R 1 67442801 Intron  C_1272321_10 rs1004819
 1 67460937 Intron  C_30279129_20 rs10489629
 1 67475114 Intron  C_31222838_10 rs11465804
 1 67491717 Intron  C_8367043_10 rs1343151
 1 67497708 Exon  C_11283764_10 rs10889677
 1 67478546 Exon  C_1272298_10 rs11209026
 1 67526096 Intergenic C_8361864_10 rs1495965
 1 67512680 Intergenic C_2720238_10 rs11209032
ERAP1 5 96150086 Intergenic C_3056885_10 rs30187
 5 96147966 Intergenic C_3056876_10 rs10050860
 5 96155291 Intergenic C_3056893_10 rs2287987
 5 96144608 Intergenic C_3056870_10 rs27044
 5 96144622 Intergenic C_3056871_10 rs17482078
LN-PEP 5 96376466 Missense Mutation C_25649482_10 rs2303138
Table II. Characteristics of the Portuguese AS cases and controls*.
 AS patients (n= 358) Controls (n=285)
Nº (%) males/ Nº (%) females              226 (63%) / 132 (37%)               127 (44.6%)/158 (55.4%)
Age, years 45.4 ± 13.3 35.9 ± 11.1
Disease duration, years 19.1 ± 12.6 
BASDAI 4.2 ± 2.3 
BASFI 4.1 ± 2.7 
BASMI 4.0 ± 2.5 
mSASSS 20.9 ± 22.9 
*Except where indicated otherwise, values are the mean ± SD (standard deviation). AS- Ankylosing 
spondylitis, BASDAI- Bath AS Disease activity Index; BASFI- Bath AS Functional Index; BASMI- 
Bath AS Metrological Index.
Table III. Frequency of ERAP1 and LNPEP minor allele frequencies in the Portuguese AS 
cohort.
  
 Portuguese Cohort
Gene SNP Minor Case Control  OR p-value
  Allele  MAF  MAF 
ERAP1 rs27044  G 0.37 0.32 1.26 (1.10-1.60) 0.044
ERAP1 rs17482078 T 0.16 0.19 0.78 (0.58-1.05) 0.096
ERAP1 rs10050860 T 0.16 0.20 0.76 (0.57-1.01) 0.057
ERAP1 rs30187 T 0.47 0.41 1.26 (1.01-1.57) 0.035
ERAP1 rs2287987 C 0.16 0.20 0.77 (0.58-1.03) 0.074
LNPEP rs2303138 A 0.08 0.07 1.23 (0.80-1.88) 0.33
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The population attributable risk frac-
tion in the Portuguese population for 
rs1004819 is 11%, and for rs30187 is 
9.7%.
The meta-analysis performed between 
Portuguese and Spanish populations 
(Table V) revealed signiﬁcant AS as-
sociations, through the ﬁxed effects, 
for SNPs rs1004819, rs11209026, 
and rs1343151. However, for mark-
ers rs11209026, rs1343151 and 
rs210889617 in particular, there were 
signiﬁcant differences in the ﬁndings 
in the Spanish and Portuguese popula-
tions, reﬂected by signiﬁcant Cochrane 
Q statistics (rs11209026, p=0.017; 
rs1343151, p=0.023; rs10889617, 
p=0.0005), suggesting that a random 
effects model should be applied. Con-
sidering the random effects models, the 
associations with AS remain signiﬁcant 
for rs1004819.
No association was observed between 
IL23R or ERAP1 variants and age of 
symptom onset, BASDAI, BASFI, 
BASMI or mSASSS (data not shown).
The study had 80% power to detect as-
sociations with these quantitative vari-
ables at a signiﬁcance level of α=0.05 
for SNPs contributing >4% of the trait 
variance, assuming linkage disequi-
librium between the marker and dis-
ease-associated variant of D’>0.8 and 
that the marker and disease-associated 
allele frequencies are equal. Consider-
ing the case-control analysis of disease 
susceptibility, assuming a population 
prevalence of disease of 0.4%, mi-
nor allele frequencies of 0.1–0.5, and 
D’>0.8, the study had 80% power to 
detect an additive association with het-
erozygote odds ratio of 1.6-1.8.
Discussion
Many candidate genes outside the MHC 
have been evaluated in different stud-
ies regarding AS susceptibility and/or 
phenotype associations. Recently, as-
sociation has been demonstrated and 
conﬁrmed with SNPs in and around the 
genes ERAP1 and IL23R in British and 
North American populations (4). 
The IL23R association with AS was 
also recently replicated in the Canadian 
(5) and Spanish (6) populations. The 
present study has replicated this asso-
ciation in the Portuguese population. 
The peak association in our cohort is 
seen with rs1004819. This is different 
from the UK, United States, Canada 
and Spanish data sets, where the peak 
association was observed for different 
SNPs, although the minor allele fre-
quencies (MAF) that we have observed 
for SNPs in Portuguese were similar 
to those reported in other British and 
North Americans. Furthermore, the as-
sociation observed in the Portuguese 
population had a similar magnitude 
of effect to the one described in those 
other populations, as can be appreciated 
by the attributable risk for rs1004819, 
which  is very similar to the one re-
ported for the most strongly associated 
SNP (rs11209032) in the British/North 
American populations (4). Interestingly, 
no association was established with 
rs11209032 in Portuguese or Spanish 
populations, which was strongly associ-
ated with AS in other Caucasian popu-
lations (4). Consistent with the Alberta 
Fig. 1.  Association results for imputed and directly genotyped SNPs in ERAP1.  Distances are in base 
pairs (bp) from the p-telomere.  Association signiﬁcance is reported as -log10(p-values).
Table IV. Frequency of IL-23R minor allele frequencies in the Portuguese and Spanish cohorts.
   
 Portuguese Cohort Spanish Cohort
Gene SNP Minor Case Control  OR p-value Case Control OR p-value
  Allele  MAF  MAF    MAF  MAF 
IL23R rs1004819 A 0.35 0.27 1.44 (1.13-1.84)     4.9x10-3 0.32 0.29 1.21 (0.99-1.33) 0.076
IL23R rs7517847 C – – –  0.38 0.40 0.93 (0.76-1.13) 0.45
IL23R rs10489629 C 0.43 0.45 0.93 (0.74-1.16) 0.51 0.42 0.46 0.92 (0.71-1.17) 0.50
IL23R rs11465804 G 0.06 0.05 1.11 (0.68-1.78)    0.68 – – – –
IL23R rs11209026 A 0.04 0.04 0.98 (0,57-1.7) 0.95 0.03 0.07 0.46 (0.28-0.75) 1x10-3
IL23R rs1343151 A 0.33 0.34 0.93 (0.74-1.18)   0.56 0.29 0.38 0.68 (0.55-0.83) 2x10-4
IL23R rs10889677 A 0.28 0.36 1.41 (1.11-1.79)    5.8x10-3 0.31 0.35 0.81 (0.65-0.99) 3.9x10-2
IL23R rs11209032 A 0.35 0.32 1.15 (0.91-1.45)  0.26 0.32 0.31 0.95 (0.77-1.16) 0.62
IL23R rs1495965 C 0.45 0.45 0.98 (0.78-1.22)  0.84 0.44 0.43 0.96 (0.79-1.16) 0.69
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Canadian population, but in contrast to 
the British, United States, Spanish and 
Canadian (Toronto and Newfoundland) 
populations, the present study did not 
demonstrate any protective effect 
against AS for the Arg381Gln SNP 
(rs11209026) in the IL23R gene. This 
apparent lack of concordance may 
be due to the different ethnical back-
grounds studied, or represent a type II 
error, given the modest power of the 
current study to detect association with 
this rare, protective, SNP. Given that 
signiﬁcant association was seen with 
other SNPs in the Portuguese popula-
tion, this suggests that rs11209026 and 
rs11209032 may not be the principal 
associated variants responsible for the 
IL23R association with AS, at least in 
the Iberian population. The imputed 
SNP data demonstrates that a broad 
region of IL23R is associated with AS 
in Portuguese. Association peaked in 
the 66kb region from rs10889667 to 
rs11465817, with a rapid reduction in 
strength of association outside of that 
region, suggesting that the primary as-
sociated variant(s) lies in that interval.
Differences are apparent between our 
Portuguese data, and the previously re-
ported Spanish data, as reﬂected by the 
signiﬁcant Cochran’s Q statistic in the 
meta-analysis of IL23R SNPs. Whilst 
statistically signiﬁcant, with one ex-
ception (rs10889617), the magnitude 
of the heterogeneity is small, reﬂected 
by the low values of the I2 statistic. 
Therefore it is not entirely clear as to 
whether a ﬁxed- or random- effects 
model should be applied, with the latter 
being more conservative and less pow-
erful. Considering the random effects, 
just 2 SNPs, rs1004819, revealed asso-
ciation (Table IV). The ﬁndings in the 
Portuguese population for rs10889677 
were very similar to those observed in 
both the discovery and replication set 
of the study by the WTCCC/TASC 
in the British and North Americans 
(4), and in marked contrast to those 
reported in the Spanish population 
(6). We observed a MAF in cases and 
controls of 34% and 28% for this SNP 
respectively, compared with 31% and 
35% in the Spanish population. In the 
WTCCC/TASC study, the MAF for this 
SNP in cases and controls respectively 
were 36% and 31% in the discovery 
cohort, and 37% and 29% in the control 
cohort. Association was seen between 
rs10889677 and AS in the Spanish 
study (OR=0.81 with minor allele ‘A’, 
P=0.039), but curiously it was in the 
opposite direction to the two cohorts 
reported by the WTCCC/TASC study, 
and our own Portuguese study.  
Numerous studies have demonstrated 
association of IL23R SNPs with suscep-
tibility to Crohn’s disease (CD) (17), 
as well as to psoriasis (18) and psori-
atic arthritis (19-21). IL23R therefore 
seems to be a common susceptibility 
factor for the major seronegative dis-
eases, at least partially explaining their 
co-occurrence. In contrast, ERAP1 is 
not associated with inﬂammatory bow-
el disease, and it is unknown whether 
it is associated with psoriasis or psori-
atic arthritis. Whether IL23R or ERAP1 
polymorphisms inﬂuence clinical man-
ifestations of disease such as age of 
symptoms onset, disease activity or se-
verity is unknown. In the current study 
no association was observed with these 
traits, but the study power was only 
adequate for large genetic effect sizes 
(>4% of the trait variance).
This study conﬁrms the association of 
ERAP1 variants with AS, with a simi-
lar magnitude of effect to that seen for 
IL23R, as assessed by the population 
attributable risk fraction. We are not 
aware of other papers that have repli-
cated this ﬁnding in populations other 
than British or North Americans. The 
strongest associated in ERAP1 was 
rs27044 (OR=1.29, 95% CI=1.02-1.63; 
p=0.032).  In contrast with IL23R, the 
association of ERAP1 seems to be con-
ﬁned to AS. No association was ob-
served between ERAP1 SNPs and either 
Crohn’s disease or ulcerative colitis in 
the WTCCC/TASC study (4). Whether 
Fig. 2.  Association results for imputed and directly genotyped SNPs in IL23R. Distances are in base 
pairs (bp) from the p-telomere. Association signiﬁcance is reported as -log10(p-values).
Table V.  Meta-analysis ﬁndings of combined Portuguese and Spanish studies of IL23R.
   
 Fixed effects Random effects
 
 Cochran Q p-value I2 OR p-value OR p-value
rs1004819 0.28 0.16 1.3 (1.11-1.52) 1.2x10-3 1.3 (1.10-1.55) 2.7x10-3
rs10489629 0.61 0 0.89 (0.76-1.03) 0.12 0.89 (0.77-1.03) 0.11
rs11209026 0.017 0.83 0.59 (0.41-0.85) 3.1x10-3 0.62 (0.26-1.5) 0.29
rs1343151 0.023 0.81 0.76 (0.65-0.89) 4x10-4 0.77 (0.54-1.1) 0.16
rs10889677 0.0005 0.92 1.02 (0.87-1.19) 0.81 1.06 (0.62-1.83) 0.83
rs11209032 0.59 0 1.09 (0.94-1.27) 0.27 1.09(0.94-1.27) 0.27
rs1495965 0.68 0 1.01(0.87-1.17) 0.90 1.01 (0.88-1.17) 0.87
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ERAP1 SNPs are associated with pso-
riasis or psoriatic arthritis is unknown. 
No association was seen with the mark-
er rs2303138 lying in LNPEP, provid-
ing further support to the hypothesis 
that at least a component of the asso-
ciation observed between this SNP and 
AS previously reported in British Cau-
casians is due to linkage disequilibrium 
with ERAP1 polymorphisms.
The primary associated variant(s) in 
ERAP1 remain uncertain. In this study, 
nominal association was seen between 
the SNPs rs26509 (96108436 from the 
p-telomere) and rs190298 (96191986 
from the p-telomere), an interval of 84 
kb. Very broad association was seen 
in the WTCCC/TASC study as well. 
Further ﬁne-mapping and resequenc-
ing studies will be required to narrow 
the associated region and identify the 
key associated variant(s) to inform 
more targeted functional analysis of 
the mechanisms of involvement of this 
gene and AS.  
Conclusions
These results show that IL23R and 
ERAP1 genes are also associated with 
susceptibility to AS in the Portuguese 
population, and that they contribute a 
signiﬁcant proportion of the population 
risk for this disease. 
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